Literature DB >> 16145051

Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY.

Afshin Raouf1, Lindsay Brown, Nikoleta Vrcelj, Karen To, Winnie Kwok, David Huntsman, Connie J Eaves.   

Abstract

The EMSY gene encodes a protein that interacts with Brca2 and is amplified in some sporadic cases of human breast cancer. To examine whether overexpression of EMSY would mimic the chromosome instability phenotype that is associated with the loss of Brca2 function, we constructed a lentiviral vector (Lenti-EMSY/GFP) that encodes a truncated form of the Emsy protein, including its Brca2-interacting domain, and green fluorescent protein (GFP) and used it to transduce human telomerase-immortalized human breast epithelial (184-hTert) cells, which have a nearly normal karyotype. At passage 5 after transduction, 39 (26%) of 150 EMSY/GFP-transduced metaphase cells contained at least one structural chromosomal abnormality compared with 19 (13%) of 150 GFP-transduced metaphase cells (P = .003, chi-square test); at passage 10, the corresponding frequencies were 42% and 15%, respectively (P < .001). Mitomycin C also produced a severalfold higher frequency of chromosome breaks in the EMSY/GFP-transduced cells than in the control cells. These results support the hypothesis that EMSY overexpression can play a role in the genesis of human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145051     DOI: 10.1093/jnci/dji254

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  17 in total

1.  Analysis of the human endogenous coregulator complexome.

Authors:  Anna Malovannaya; Rainer B Lanz; Sung Yun Jung; Yaroslava Bulynko; Nguyen T Le; Doug W Chan; Chen Ding; Yi Shi; Nur Yucer; Giedre Krenciute; Beom-Jun Kim; Chunshu Li; Rui Chen; Wei Li; Yi Wang; Bert W O'Malley; Jun Qin
Journal:  Cell       Date:  2011-05-27       Impact factor: 41.582

2.  Robust high-performance nanoliter-volume single-cell multiple displacement amplification on planar substrates.

Authors:  Kaston Leung; Anders Klaus; Bill K Lin; Emma Laks; Justina Biele; Daniel Lai; Ali Bashashati; Yi-Fei Huang; Radhouane Aniba; Michelle Moksa; Adi Steif; Anne-Marie Mes-Masson; Martin Hirst; Sohrab P Shah; Samuel Aparicio; Carl L Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-13       Impact factor: 11.205

Review 3.  The function of EMSY in cancer development.

Authors:  Jing Hou; Ziliang Wang; Lina Yang; Xiaomao Guo; Gong Yang
Journal:  Tumour Biol       Date:  2014-03-09

4.  Amplification of EMSY gene in a subset of sporadic pancreatic adenocarcinomas.

Authors:  W Arnout van Hattem; Ralph Carvalho; Ang Li; G Johan A Offerhaus; Michael Goggins
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis.

Authors:  Zihao Wang; Namrata D Udeshi; Chad Slawson; Philip D Compton; Kaoru Sakabe; Win D Cheung; Jeffrey Shabanowitz; Donald F Hunt; Gerald W Hart
Journal:  Sci Signal       Date:  2010-01-12       Impact factor: 8.192

6.  Structural basis for recruitment of BRCA2 by PALB2.

Authors:  Antony W Oliver; Sally Swift; Christopher J Lord; Alan Ashworth; Laurence H Pearl
Journal:  EMBO Rep       Date:  2009-07-17       Impact factor: 8.807

7.  Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations.

Authors:  Konstantin J Dedes; Paul M Wilkerson; Daniel Wetterskog; Britta Weigelt; Alan Ashworth; Jorge S Reis-Filho
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

8.  EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.

Authors:  Isabelle Cousineau; Abdellah Belmaaza
Journal:  Mol Genet Genomics       Date:  2011-03-16       Impact factor: 3.291

9.  Loss of Xenopus tropicalis EMSY causes impairment of gastrulation and upregulation of p53.

Authors:  Amer A Rana; Stephen J Roper; Elizabeth A Palmer; James C Smith
Journal:  N Biotechnol       Date:  2010-11-05       Impact factor: 5.079

10.  YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification.

Authors:  A H Davies; I Barrett; M R Pambid; K Hu; A L Stratford; S Freeman; I M Berquin; S Pelech; P Hieter; C Maxwell; S E Dunn
Journal:  Oncogene       Date:  2011-03-21       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.